Physician profile
Kristi Lynn Orme
NPI 1750912135
$1,104.32
in general payments reported to CMS, 2019-2025
13 companies · $51.81 in 2025
The $51.81 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.78 · 2022: $542 · 2023: $306 · 2024: $154 · 2025: $51.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $443.15 | 2022-2023 | Kimyrsa, Vabomere, Rezzayo |
| Gilead Sciences, INC. | $208.88 | 2021-2024 | |
| Insmed, INC. | $96.11 | 2021-2023 | Arikayce |
| La Jolla Pharmaceutical Company | $94.23 | 2021-2023 | Giapreza, Xerava |
| Shionogi INC | $42.40 | 2022-2023 | Fetroja |
| Merck Sharp & Dohme LLC | $40.65 | 2024 | Pifeltro, Delstrigo, Gardasil |
| Novo Nordisk INC | $39.84 | 2024 | Ozempic |
| Paratek Pharmaceuticals, INC. | $39.15 | 2022 | |
| Bioventus LLC | $29.76 | 2025 | Exogen Ultrasound Bone Healing System |
| Mimedx Group, INC. | $22.05 | 2025 | |
| Amgen INC. | $17.58 | 2024 | Otezla, Repatha |
| Lundbeck LLC | $16.64 | 2024 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.88 | 2024 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristi Orme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.